Loading...

Holly Ingraham, PhD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentCellular Molecular Pharmacology
Address1550 Fourth St
San Francisco CA 94158
Phone415-476-2731
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    UCSF Nutrition Obesity Research Center
    NIH/NIDDK P30DK098722Aug 1, 2015 - Jul 31, 2020
    Role: Co-Investigator
    Mapping Hypothalamic Neurocircuits Controlling Physical Activity
    NIH/NIDDK R01DK099722Apr 1, 2014 - Mar 31, 2019
    Role: Principal Investigator
    Molecular Mechanisms of Atrazine in Altering the Endocrine Gene Network
    NIH/NIEHS R21ES017136Jul 1, 2009 - Jun 30, 2011
    Role: Principal Investigator
    IRACDA Scholars in Science (ISIS) Program
    NIH/NIGMS K12GM081266Aug 3, 2007 - Jul 31, 2017
    Role: Principal Investigator
    Structural Analyses of NR5 Orphan Nuclear Receptors
    NIH/NIDDK R01DK072246Jul 15, 2005 - May 31, 2012
    Role: Principal Investigator
    Modulating Nuclear Receptor Activity via Sumoylation
    NIH/NIDDK R01DK070024Sep 30, 2004 - Jul 31, 2013
    Role: Principal Investigator
    STRUCTURE AND DYNAMICS OF NUCLEAR RECEPTORS
    NIH/NIDDK P01DK058390Aug 15, 2000 - Jul 31, 2006
    Role: Co-Investigator
    30TH GORDON CONFERENCE ON HORMONE ACTION
    NIH/NIDDK R13DK056229Jul 15, 1999 - Jun 30, 2000
    Role: Principal Investigator
    CELLULAR SIGNALING IN REPRODUCTIVE TRACT DEVELOPMENT
    NIH/NICHD R01HD036233Apr 15, 1998 - Mar 31, 2004
    Role: Principal Investigator
    GENE EXPRESSION IN MAMMALIAN REPRODUCTIVE DEVELOPMENT
    NIH/NICHD K02HD001178Jul 1, 1997 - Jun 30, 2002
    Role: Principal Investigator
    Developmental Programs of Neural Circuits in the Mouse Medial Hypothalamus
    NIH/NIDDK R01DK063592Aug 1, 1993 - Mar 31, 2014
    Role: Principal Investigator
    GENE REGULATION IN MAMMALIAN SEX DETERMINATION
    NIH/NICHD R01HD030725Aug 1, 1993 - Jul 31, 2002
    Role: Principal Investigator
    MOLECULAR ANALYSIS OF PITUITARY DEVELOPMENT
    NIH/NIDDK R01DK046048Jul 1, 1993 - Jun 30, 1997
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Selected Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. de Jesus Cortez F, Suzawa M, Irvy S, Bruning JM, Sablin E, Jacobson MP, Fletterick RJ, Ingraham HA, England PM. Disulfide-Trapping Identifies a New, Effective Chemical Probe for Activating the Nuclear Receptor Human LRH-1 (NR5A2). PLoS One. 2016; 11(7):e0159316. PMID: 27467220.
      View in: PubMed
    2. Correa SM, Newstrom DW, Warne JP, Flandin P, Cheung CC, Lin-Moore AT, Pierce AA, Xu AW, Rubenstein JL, Ingraham HA. An estrogen-responsive module in the ventromedial hypothalamus selectively drives sex-specific activity in females. Cell Rep. 2015 Jan 6; 10(1):62-74. PMID: 25543145; PMCID: PMC4324838 [Available on 01/06/16].
    3. Blind RD, Sablin EP, Kuchenbecker KM, Chiu HJ, Deacon AM, Das D, Fletterick RJ, Ingraham HA. The signaling phospholipid PIP3 creates a new interaction surface on the nuclear receptor SF-1. Proc Natl Acad Sci U S A. 2014 Oct 21; 111(42):15054-9. PMID: 25288771; PMCID: PMC4210282.
    4. Cheung CC, Kurrasch DM, Liang JK, Ingraham HA. Genetic labeling of steroidogenic factor-1 (SF-1) neurons in mice reveals ventromedial nucleus of the hypothalamus (VMH) circuitry beginning at neurogenesis and development of a separate non-SF-1 neuronal cluster in the ventrolateral VMH. J Comp Neurol. 2013 Apr 15; 521(6):1268-88. PMID: 22987798; PMCID: PMC4304766.
    5. Blind RD, Suzawa M, Ingraham HA. Direct modification and activation of a nuclear receptor-PIP2 complex by the inositol lipid kinase IPMK. Sci Signal. 2012 Jun 19; 5(229):ra44. PMID: 22715467; PMCID: PMC3395721.
    6. Ziv L, Muto A, Schoonheim PJ, Meijsing SH, Strasser D, Ingraham HA, Schaaf MJ, Yamamoto KR, Baier H. An affective disorder in zebrafish with mutation of the glucocorticoid receptor. Mol Psychiatry. 2013 Jun; 18(6):681-91. PMID: 22641177; PMCID: PMC4065652.
    7. Lee FY, Faivre EJ, Suzawa M, Lontok E, Ebert D, Cai F, Belsham DD, Ingraham HA. Eliminating SF-1 (NR5A1) sumoylation in vivo results in ectopic hedgehog signaling and disruption of endocrine development. Dev Cell. 2011 Aug 16; 21(2):315-27. PMID: 21820362; PMCID: PMC3157481.
    8. Ingraham HA. Metabolism: A lipid for fat disorders. Nature. 2011 Jun 23; 474(7352):455-6. PMID: 21697939.
      View in: PubMed
    9. Hayes TB, Anderson LL, Beasley VR, de Solla SR, Iguchi T, Ingraham H, Kestemont P, Kniewald J, Kniewald Z, Langlois VS, Luque EH, McCoy KA, Muñoz-de-Toro M, Oka T, Oliveira CA, Orton F, Ruby S, Suzawa M, Tavera-Mendoza LE, Trudeau VL, Victor-Costa AB, Willingham E. Demasculinization and feminization of male gonads by atrazine: consistent effects across vertebrate classes. J Steroid Biochem Mol Biol. 2011 Oct; 127(1-2):64-73. PMID: 21419222; PMCID: PMC4303243.
    10. Whitby RJ, Stec J, Blind RD, Dixon S, Leesnitzer LM, Orband-Miller LA, Williams SP, Willson TM, Xu R, Zuercher WJ, Cai F, Ingraham HA. Small molecule agonists of the orphan nuclear receptors steroidogenic factor-1 (SF-1, NR5A1) and liver receptor homologue-1 (LRH-1, NR5A2). J Med Chem. 2011 Apr 14; 54(7):2266-81. PMID: 21391689; PMCID: PMC4151520.
    11. Blackshaw S, Scholpp S, Placzek M, Ingraham H, Simerly R, Shimogori T. Molecular pathways controlling development of thalamus and hypothalamus: from neural specification to circuit formation. J Neurosci. 2010 Nov 10; 30(45):14925-30. PMID: 21068293.
      View in: PubMed
    12. Mullaney BC, Blind RD, Lemieux GA, Perez CL, Elle IC, Faergeman NJ, Van Gilst MR, Ingraham HA, Ashrafi K. Regulation of C. elegans fat uptake and storage by acyl-CoA synthase-3 is dependent on NR5A family nuclear hormone receptor nhr-25. Cell Metab. 2010 Oct 6; 12(4):398-410. PMID: 20889131; PMCID: PMC2992884.
    13. Lin BC, Suzawa M, Blind RD, Tobias SC, Bulun SE, Scanlan TS, Ingraham HA. Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation. Cancer Res. 2009 Jul 1; 69(13):5415-23. PMID: 19549922; PMCID: PMC2756996.
    14. Kurrasch DM, Nevin LM, Wong JS, Baier H, Ingraham HA. Neuroendocrine transcriptional programs adapt dynamically to the supply and demand for neuropeptides as revealed in NSF mutant zebrafish. Neural Dev. 2009; 4:22. PMID: 19549326; PMCID: PMC2715394.
    15. Sablin EP, Woods A, Krylova IN, Hwang P, Ingraham HA, Fletterick RJ. The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1. Proc Natl Acad Sci U S A. 2008 Nov 25; 105(47):18390-5. PMID: 19015525; PMCID: PMC2587556.
    16. Sablin EP, Blind RD, Krylova IN, Ingraham JG, Cai F, Williams JD, Fletterick RJ, Ingraham HA. Structure of SF-1 bound by different phospholipids: evidence for regulatory ligands. Mol Endocrinol. 2009 Jan; 23(1):25-34. PMID: 18988706; PMCID: PMC2646595.
    17. Campbell LA, Faivre EJ, Show MD, Ingraham JG, Flinders J, Gross JD, Ingraham HA. Decreased recognition of SUMO-sensitive target genes following modification of SF-1 (NR5A1). Mol Cell Biol. 2008 Dec; 28(24):7476-86. PMID: 18838537; PMCID: PMC2593425.
    18. Suzawa M, Ingraham HA. The herbicide atrazine activates endocrine gene networks via non-steroidal NR5A nuclear receptors in fish and mammalian cells. PLoS One. 2008; 3(5):e2117. PMID: 18461179; PMCID: PMC2362696.
    19. Kurrasch DM, Cheung CC, Lee FY, Tran PV, Hata K, Ingraham HA. The neonatal ventromedial hypothalamus transcriptome reveals novel markers with spatially distinct patterning. J Neurosci. 2007 Dec 12; 27(50):13624-34. PMID: 18077674.
      View in: PubMed
    20. Benoit G, Cooney A, Giguere V, Ingraham H, Lazar M, Muscat G, Perlmann T, Renaud JP, Schwabe J, Sladek F, Tsai MJ, Laudet V. International Union of Pharmacology. LXVI. Orphan nuclear receptors. Pharmacol Rev. 2006 Dec; 58(4):798-836. PMID: 17132856.
      View in: PubMed
    21. Tran PV, Akana SF, Malkovska I, Dallman MF, Parada LF, Ingraham HA. Diminished hypothalamic bdnf expression and impaired VMH function are associated with reduced SF-1 gene dosage. J Comp Neurol. 2006 Oct 10; 498(5):637-48. PMID: 16917842.
      View in: PubMed
    22. Ingraham HA, Redinbo MR. Orphan nuclear receptors adopted by crystallography. Curr Opin Struct Biol. 2005 Dec; 15(6):708-15. PMID: 16263271.
      View in: PubMed
    23. Lee MB, Lebedeva LA, Suzawa M, Wadekar SA, Desclozeaux M, Ingraham HA. The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification. Mol Cell Biol. 2005 Mar; 25(5):1879-90. PMID: 15713642; PMCID: PMC549377.
    24. Krylova IN, Sablin EP, Moore J, Xu RX, Waitt GM, MacKay JA, Juzumiene D, Bynum JM, Madauss K, Montana V, Lebedeva L, Suzawa M, Williams JD, Williams SP, Guy RK, Thornton JW, Fletterick RJ, Willson TM, Ingraham HA. Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell. 2005 Feb 11; 120(3):343-55. PMID: 15707893.
      View in: PubMed
    25. Bland ML, Fowkes RC, Ingraham HA. Differential requirement for steroidogenic factor-1 gene dosage in adrenal development versus endocrine function. Mol Endocrinol. 2004 Apr; 18(4):941-52. PMID: 14726490.
      View in: PubMed
    26. Jordan BK, Shen JH, Olaso R, Ingraham HA, Vilain E. Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/beta-catenin synergy. Proc Natl Acad Sci U S A. 2003 Sep 16; 100(19):10866-71. PMID: 12949260; PMCID: PMC196894.
    27. Fowkes RC, Desclozeaux M, Patel MV, Aylwin SJ, King P, Ingraham HA, Burrin JM. Steroidogenic factor-1 and the gonadotrope-specific element enhance basal and pituitary adenylate cyclase-activating polypeptide-stimulated transcription of the human glycoprotein hormone alpha-subunit gene in gonadotropes. Mol Endocrinol. 2003 Nov; 17(11):2177-88. PMID: 12920232.
      View in: PubMed
    28. Bland ML, Desclozeaux M, Ingraham HA. Tissue growth and remodeling of the embryonic and adult adrenal gland. Ann N Y Acad Sci. 2003 May; 995:59-72. PMID: 12814939.
      View in: PubMed
    29. Tran PV, Lee MB, Marín O, Xu B, Jones KR, Reichardt LF, Rubenstein JR, Ingraham HA. Requirement of the orphan nuclear receptor SF-1 in terminal differentiation of ventromedial hypothalamic neurons. Mol Cell Neurosci. 2003 Apr; 22(4):441-53. PMID: 12727442; PMCID: PMC2710097.
    30. Huber BR, Desclozeaux M, West BL, Cunha-Lima ST, Nguyen HT, Baxter JD, Ingraham HA, Fletterick RJ. Thyroid hormone receptor-beta mutations conferring hormone resistance and reduced corepressor release exhibit decreased stability in the N-terminal ligand-binding domain. Mol Endocrinol. 2003 Jan; 17(1):107-16. PMID: 12511610.
      View in: PubMed
    31. Desclozeaux M, Krylova IN, Horn F, Fletterick RJ, Ingraham HA. Phosphorylation and intramolecular stabilization of the ligand binding domain in the nuclear receptor steroidogenic factor 1. Mol Cell Biol. 2002 Oct; 22(20):7193-203. PMID: 12242296; PMCID: PMC139795.
    32. Roberts LM, Visser JA, Ingraham HA. Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development. Development. 2002 Mar; 129(6):1487-96. PMID: 11880357.
      View in: PubMed
    33. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Ingraham HA, Nachtigal MW, Uilenbroek JT, Grootegoed JA, Themmen AP. Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology. 2002 Mar; 143(3):1076-84. PMID: 11861535.
      View in: PubMed
    34. Shen JH, Ingraham HA. Regulation of the orphan nuclear receptor steroidogenic factor 1 by Sox proteins. Mol Endocrinol. 2002 Mar; 16(3):529-40. PMID: 11875113.
      View in: PubMed
    35. Visser JA, Olaso R, Verhoef-Post M, Kramer P, Themmen AP, Ingraham HA. The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling. Mol Endocrinol. 2001 Jun; 15(6):936-45. PMID: 11376112.
      View in: PubMed
    36. McGee EA, Smith R, Spears N, Nachtigal MW, Ingraham H, Hsueh AJ. Müllerian inhibitory substance induces growth of rat preantral ovarian follicles. Biol Reprod. 2001 Jan; 64(1):293-8. PMID: 11133686.
      View in: PubMed
    37. Bland ML, Jamieson CA, Akana SF, Bornstein SR, Eisenhofer G, Dallman MF, Ingraham HA. Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response. Proc Natl Acad Sci U S A. 2000 Dec 19; 97(26):14488-93. PMID: 11121051; PMCID: PMC18946.
    38. Bland ML, Jamieson C, Akana S, Dallman M, Ingraham HA. Gene dosage effects of steroidogenic factor 1 (SF-1) in adrenal development and the stress. Endocr Res. 2000 Nov; 26(4):515-6. PMID: 11196422.
      View in: PubMed
    39. Ingraham HA, Hirokawa Y, Roberts LM, Mellon SH, McGee E, Nachtigal MW, Visser JA. Autocrine and paracrine Müllerian inhibiting substance hormone signaling in reproduction. Recent Prog Horm Res. 2000; 55:53-67; discussion 67-8. PMID: 11036933.
      View in: PubMed
    40. Roberts LM, Shen J, Ingraham HA. New solutions to an ancient riddle: defining the differences between Adam and Eve. Am J Hum Genet. 1999 Oct; 65(4):933-42. PMID: 10486311; PMCID: PMC1288263.
    41. Hammer GD, Ingraham HA. Steroidogenic factor-1: its role in endocrine organ development and differentiation. Front Neuroendocrinol. 1999 Jul; 20(3):199-223. PMID: 10433862.
      View in: PubMed
    42. Hammer GD, Krylova I, Zhang Y, Darimont BD, Simpson K, Weigel NL, Ingraham HA. Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress. Mol Cell. 1999 Apr; 3(4):521-6. PMID: 10230405.
      View in: PubMed
    43. Roberts LM, Hirokawa Y, Nachtigal MW, Ingraham HA. Paracrine-mediated apoptosis in reproductive tract development. Dev Biol. 1999 Apr 1; 208(1):110-22. PMID: 10075845.
      View in: PubMed
    44. Bedford FK, Julius D, Ingraham HA. Neuronal expression of the 5HT3 serotonin receptor gene requires nuclear factor 1 complexes. J Neurosci. 1998 Aug 15; 18(16):6186-94. PMID: 9698312.
      View in: PubMed
    45. Nachtigal MW, Hirokawa Y, Enyeart-VanHouten DL, Flanagan JN, Hammer GD, Ingraham HA. Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell. 1998 May 1; 93(3):445-54. PMID: 9590178.
      View in: PubMed
    46. Giuili G, Shen WH, Ingraham HA. The nuclear receptor SF-1 mediates sexually dimorphic expression of Mullerian Inhibiting Substance, in vivo. Development. 1997 May; 124(9):1799-807. PMID: 9165127.
      View in: PubMed
    47. Nachtigal MW, Ingraham HA. Bioactivation of Müllerian inhibiting substance during gonadal development by a kex2/subtilisin-like endoprotease. Proc Natl Acad Sci U S A. 1996 Jul 23; 93(15):7711-6. PMID: 8755541; PMCID: PMC38812.
    48. Bedford FK, Christopherson K, Nachtigal MW, Shen WH, Julius DJ, Ingraham HA. Molecular biology of pituitary development and disease. Horm Res. 1996; 45 Suppl 1:19-21. PMID: 8805023.
      View in: PubMed
    49. Ingraham HA, Lala DS, Ikeda Y, Luo X, Shen WH, Nachtigal MW, Abbud R, Nilson JH, Parker KL. The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev. 1994 Oct 1; 8(19):2302-12. PMID: 7958897.
      View in: PubMed
    50. Shen WH, Moore CC, Ikeda Y, Parker KL, Ingraham HA. Nuclear receptor steroidogenic factor 1 regulates the müllerian inhibiting substance gene: a link to the sex determination cascade. Cell. 1994 Jun 3; 77(5):651-61. PMID: 8205615.
      View in: PubMed
    51. Ikeda Y, Shen WH, Ingraham HA, Parker KL. Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol Endocrinol. 1994 May; 8(5):654-62. PMID: 8058073.
      View in: PubMed
    52. Pfäffle RW, DiMattia GE, Parks JS, Brown MR, Wit JM, Jansen M, Van der Nat H, Van den Brande JL, Rosenfeld MG, Ingraham H. Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science. 1992 Aug 21; 257(5073):1118-21. PMID: 1509263.
      View in: PubMed
    53. Carpenter CD, Ingraham H, Cochet C, Walton GM, Lazar CS, Sowadski JM, Rosenfeld MG, Gill GN. Structural analysis of the transmembrane domain of the epidermal growth factor receptor. J Biol Chem. 1991 Mar 25; 266(9):5750-5. PMID: 2005111.
      View in: PubMed
    54. Chen RP, Ingraham H, Treacy MN, Albert VR, Wilson L, Rosenfeld MG. Autoregulation of pit-1 gene expression mediated by two cis-active promoter elements. Nature. 1990 Aug 9; 346(6284):583-6. PMID: 2142999.
      View in: PubMed
    55. Heisermann GJ, Wiley HS, Walsh BJ, Ingraham H, Fiol CJ, Gill GN. Mutational removal of the Thr669 and Ser671 phosphorylation sites alters substrate specificity and ligand-induced internalization of the epidermal growth factor receptor. J Biol Chem. 1990 Aug 5; 265(22):12820-7. PMID: 2115882.
      View in: PubMed
    56. Ingraham HA, Flynn SE, Voss JW, Albert VR, Kapiloff MS, Wilson L, Rosenfeld MG. The POU-specific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA-dependent Pit-1-Pit-1 interactions. Cell. 1990 Jun 15; 61(6):1021-33. PMID: 2350782.
      View in: PubMed
    57. Simmons DM, Voss JW, Ingraham H, Holloway JM, Broide RS, Rosenfeld MG, Swanson LW. Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Genes Dev. 1990 May; 4(5):695-711. PMID: 2379827.
      View in: PubMed
    58. Ingraham HA, Albert VR, Chen RP, Crenshaw 3d EB, Elsholtz HP, He X, Kapiloff MS, Mangalam HJ, Swanson LW, Treacy MN. A family of POU-domain and Pit-1 tissue-specific transcription factors in pituitary and neuroendocrine development. Annu Rev Physiol. 1990; 52:773-91. PMID: 2184776.
      View in: PubMed
    59. He X, Treacy MN, Simmons DM, Ingraham H, Swanson LW, Rosenfeld MG. Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature. 1989 Jul 6; 340(6228):35-41. PMID: 2739723.
      View in: PubMed
    60. Mangalam HJ, Albert VR, Ingraham H, Kapiloff M, Wilson L, Nelson C, Elsholtz H, Rosenfeld MG. A pituitary POU domain protein, Pit-1, activates both growth hormone and prolactin promoters transcriptionally. Genes Dev. 1989 Jul; 3(7):946-58. PMID: 2550324.
      View in: PubMed
    61. Herr W, Sturm RA, Clerc RG, Corcoran LM, Baltimore D, Sharp PA, Ingraham HA, Rosenfeld MG, Finney M, Ruvkun G. The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev. 1988 Dec; 2(12A):1513-6. PMID: 3215510.
      View in: PubMed
    62. Ingraham H, Chen RP, Mangalam HJ, Elsholtz HP, Flynn SE, Lin CR, Simmons DM, Swanson L, Rosenfeld MG. A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell. 1988 Nov 4; 55(3):519-29. PMID: 2902928.
      View in: PubMed
    63. Gill GN, Chen WS, Lazar CS, Glenney JR, Wiley HS, Ingraham H, Rosenfeld MG. Role of intrinsic protein tyrosine kinase in function and metabolism of the epidermal growth factor receptor. Cold Spring Harb Symp Quant Biol. 1988; 53 Pt 1:467-76. PMID: 3254778.
      View in: PubMed
    64. Ingraham H, Evans GA. Characterization of two atypical promoters and alternate mRNA processing in the mouse Thy-1.2 glycoprotein gene. Mol Cell Biol. 1986 Aug; 6(8):2923-31. PMID: 2878365; PMCID: PMC367861.
    65. Ingraham HA, Dickey L, Goulian M. DNA fragmentation and cytotoxicity from increased cellular deoxyuridylate. Biochemistry. 1986 Jun 3; 25(11):3225-30. PMID: 3524674.
      View in: PubMed
    66. Ingraham H, Lawless GM, Evans GA. The mouse Thy-1.2 glycoprotein gene: complete sequence and identification of an unusual promoter. J Immunol. 1986 Feb 15; 136(4):1482-9. PMID: 2868059.
      View in: PubMed
    67. Goulian M, Bleile BM, Dickey LM, Grafstrom RH, Ingraham H, Neynaber SA, Peterson MS, Tseng BY. Mechanism of thymineless death. Adv Exp Med Biol. 1986; 195 Pt B:89-95. PMID: 3020930.
      View in: PubMed
    68. Evans GA, Ingraham HA, Lewis K, Cunningham K, Seki T, Moriuchi T, Chang HC, Silver J, Hyman R. Expression of the Thy-1 glycoprotein gene by DNA-mediated gene transfer. Proc Natl Acad Sci U S A. 1984 Sep; 81(17):5532-6. PMID: 6147849; PMCID: PMC391740.
    69. Peterson MS, Ingraham HA, Goulian M. 2'-deoxyribosyl analogues of UDP-N-acetylglucosamine in cells treated with methotrexate or 5-fluorodeoxyuridine. J Biol Chem. 1983 Sep 25; 258(18):10831-4. PMID: 6224793.
      View in: PubMed
    70. Patrick J, Ballivet M, Boas L, Claudio T, Forrest J, Ingraham H, Mason P, Stengelin S, Ueno S, Heinemann S. Molecular cloning of the acetylcholine receptor. Cold Spring Harb Symp Quant Biol. 1983; 48 Pt 1:71-8. PMID: 6202451.
      View in: PubMed
    71. Ingraham HA, Goulian M. Deoxyuridine triphosphatase: a potential site of interaction with pyrimidine nucleotide analogues. Biochem Biophys Res Commun. 1982 Dec 15; 109(3):746-52. PMID: 6130763.
      View in: PubMed
    72. Ingraham HA, Tseng BY, Goulian M. Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine. Mol Pharmacol. 1982 Jan; 21(1):211-6. PMID: 6215571.
      View in: PubMed
    73. Ingraham HA, Tseng BY, Goulian M. Mechanism for exclusion of 5-fluorouracil from DNA. Cancer Res. 1980 Apr; 40(4):998-1001. PMID: 6101994.
      View in: PubMed
    74. Ingraham H, Alhadeff JA. Characterization of sialytransferase in noncancerous and neoplastic human liver tissue. J Natl Cancer Inst. 1978 Dec; 61(6):1371-4. PMID: 82633.
      View in: PubMed
    75. Barrieux A, Ingraham H, Nystul S, Rosenfeld MG. Characterization of the association of specific proteins with messenger ribonucleic acid. Biochemistry. 1976 Aug 10; 15(16):3523-8. PMID: 952875.
      View in: PubMed
    76. Barrieux A, Ingraham H, David DN, Rosenfeld MG. Isolation of messenger-like ribonucleoproteins. Biochemistry. 1975 May 6; 14(9):1815-21. PMID: 1125199.
      View in: PubMed
    77. INGRAHAM HA, GARDNER MM, HEUS EG. A report on 159 third degree lacerations. Am J Obstet Gynecol. 1949 Apr; 57(4):730-5. PMID: 18113702.
      View in: PubMed
    Holly's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP